Integra Accounts Payable from 2010 to 2024
IART Stock | USD 24.24 0.66 2.80% |
Accounts Payable | First Reported 1995-09-30 | Previous Quarter 107.5 M | Current Value 77.7 M | Quarterly Volatility 33 M |
Check Integra LifeSciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Integra LifeSciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 129.7 M, Interest Expense of 53.9 M or Total Revenue of 1.6 B, as well as many indicators such as Price To Sales Ratio of 4.18, Dividend Yield of 3.0E-4 or PTB Ratio of 3.52. Integra financial statements analysis is a perfect complement when working with Integra LifeSciences Valuation or Volatility modules.
Integra | Accounts Payable |
Latest Integra LifeSciences' Accounts Payable Growth Pattern
Below is the plot of the Accounts Payable of Integra LifeSciences Holdings over the last few years. An accounting item on the balance sheet that represents Integra LifeSciences obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Integra LifeSciences are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Integra LifeSciences' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Integra LifeSciences' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable | 10 Years Trend |
|
Accounts Payable |
Timeline |
Integra Accounts Payable Regression Statistics
Arithmetic Mean | 60,283,953 | |
Geometric Mean | 40,570,268 | |
Coefficient Of Variation | 55.98 | |
Mean Deviation | 28,576,617 | |
Median | 54,608,000 | |
Standard Deviation | 33,749,867 | |
Sample Variance | 1139.1T | |
Range | 112.8M | |
R-Value | 0.80 | |
Mean Square Error | 431.9T | |
R-Squared | 0.65 | |
Significance | 0.0003 | |
Slope | 6,074,711 | |
Total Sum of Squares | 15946.7T |
Integra Accounts Payable History
About Integra LifeSciences Financial Statements
Integra LifeSciences shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although Integra LifeSciences investors may analyze each financial statement separately, they are all interrelated. The changes in Integra LifeSciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Integra LifeSciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last Reported | Projected for Next Year | ||
Accounts Payable | 92.3 M | 96.9 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Integra Stock Analysis
When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.